Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDivestmentsFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Share-based Compensation (2020 - 2026)

Cresco Labs filings provide 7 years of Share-based Compensation readings, the most recent being $5.3 million for Q1 2026.

  • On a quarterly basis, Share-based Compensation rose 92.99% to $5.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $13.8 million, a 8.47% increase, with the full-year FY2025 number at $11.2 million, down 20.69% from a year prior.
  • Share-based Compensation hit $5.3 million in Q1 2026 for Cresco Labs, up from $3.7 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $7.5 million in Q1 2022 to a low of $2.2 million in Q2 2023.
  • Median Share-based Compensation over the past 5 years was $3.7 million (2025), compared with a mean of $4.1 million.
  • Biggest five-year swings in Share-based Compensation: plummeted 70.4% in 2023 and later surged 92.99% in 2026.
  • Cresco Labs' Share-based Compensation stood at $5.3 million in 2022, then crashed by 42.76% to $3.0 million in 2023, then grew by 22.8% to $3.7 million in 2024, then dropped by 1.4% to $3.7 million in 2025, then surged by 43.85% to $5.3 million in 2026.
  • The last three reported values for Share-based Compensation were $5.3 million (Q1 2026), $3.7 million (Q4 2025), and $2.3 million (Q3 2025) per Business Quant data.